Skip to content

    BIO-RAD LABORATORIES (BIO) stock price & financials

    View BIO earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+32.4% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $649.70M
    $667.50M
    $585.40M
    $651.60M
    $653.00M
    +0.5%
    $693.20M
    +3.9%
    $592.10M
    +1.1%
    $651.00M
    -0.1%
    Stable
    Operating Profit
    $64.50M
    $58.40M
    $23.70M
    $77.10M
    $65.30M
    +1.2%
    -$118.90M
    -303.6%
    $34.10M
    +43.9%
    $72.60M
    -5.8%
    Weakening
    Net Profit
    $653.20M
    -$715.80M
    $64.00M
    $317.80M
    -$341.90M
    -152.3%
    $720.00M
    -$527.10M
    -923.6%
    $371.40M
    +16.9%
    Weakening
    EPS
    $23.37
    $-25.57
    $2.29
    $11.67
    $-12.70
    -154.3%
    $-19.55
    -953.7%
    $13.89
    +19.0%
    Weakening
    Other Income
    Interest
    $12.10M
    $12.20M
    $12.00M
    $12.60M
    $12.30M
    +1.7%
    $12.10M
    -0.8%
    $12.30M
    +2.5%
    $12.10M
    -4.0%
    Stable
    Depreciation
    Profit before Tax
    $861.60M
    -$908.90M
    $83.40M
    $414.00M
    -$431.10M
    -150.0%
    $929.20M
    -$689.80M
    -927.1%
    $542.10M
    +30.9%
    Weakening
    MarginsOPM
    9.9%
    8.8%
    4.0%
    11.8%
    10.0%
    +0.7%
    -17.1%
    -296.0%
    5.8%
    +42.2%
    11.2%
    -5.7%
    Weakening
    Tax
    24.2%
    21.3%
    23.3%
    23.2%
    20.7%
    -14.5%
    22.5%
    +5.9%
    23.6%
    +1.4%
    31.5%
    +35.5%
    Strengthening
    ReturnsROIC
    8.1%
    -8.9%
    0.8%
    4.0%
    -4.3%
    -152.3%
    9.0%
    -6.6%
    -923.6%
    4.6%
    +16.9%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$431.53M$660.67M$662.21M$470.78M$434.20M$403.80M$488.10M$529.80M$517.00M
    Short-Term Investments
    Total Current Assets$2.02B$2.18B$2.14B$1.99B$3.16B$3.05B$3.03B$2.91B$3.02B
    Net PP&E$508.69M$701.21M$693.51M$716.44M$679.56M$723.70M$688.60M$709.90M$671.90M
    Goodwill$219.80M$264.10M$291.90M$347.30M$406.50M$413.60M$410.50M$579.80M$574.30M
    Intangibles$133.12M$145.53M$199.50M$253.94M$332.15M$320.50M$293.60M$174.30M$160.00M
    Total Assets$5.61B$8.01B$12.97B$17.80B$13.50B$12.30B$9.36B$10.58B$10.25B
    LiabilitiesTotal Current Liabilities$450.80M$905.50M$631.54M$680.94M$568.71M$522.80M$467.80M$517.00M$961.30M
    Short-Term Debt
    Long-Term Debt$438.94M$13.58M$12.26M$10.51M$1.20B$1.20B$1.20B$1.20B$803.00M
    Long-Term Leases$0$176.02M$175.13M$175.94M$153.60M$165.50M$131.40M$145.70M$133.10M
    Total Liabilities$1.59B$2.25B$3.09B$4.11B$3.89B$3.56B$2.79B$3.12B$3.08B
    EquityCommon Stock & APIC
    Retained Earnings$3.72B$5.47B$9.27B$13.53B$9.90B$9.26B$7.42B$8.18B$8.02B
    Total Equity$4.02B$5.76B$9.89B$13.69B$9.62B$8.74B$6.57B$7.45B$7.17B
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating$285.49M$457.90M$584.97M$669.46M$194.40M$374.90M$455.20M$532.20M$492.60M
    Cash from Investing-$186.98M-$208.89M-$69.89M-$797.38M-$1.21B$20.20M-$160.20M-$189.70M-$237.10M
    Cash from Financing-$48.68M-$22.76M-$523.04M-$55.43M$973.60M-$425.60M-$218.80M-$283.20M-$120.80M
    SummaryCapital Expenditure-$129.82M-$98.53M-$108.56M-$133.75M-$112.80M-$156.70M-$165.60M-$157.60M-$139.50M
    Free Cash Flow$155.67M$359.37M$476.41M$535.72M$81.60M$218.20M$289.60M$374.60M$353.10M
    FCF Margin6.8%15.5%18.7%18.3%2.9%8.2%11.3%14.5%13.6%

    Ratios